Effects of Gender of Reciprocal Chromosomal Translocation on Blastocyst Formation and Pregnancy Outcome in Preimplantation Genetic Testing.
Abortion, Spontaneous
/ epidemiology
Adult
Birth Rate
Blastocyst
/ cytology
Embryo Transfer
Female
Fertilization in Vitro
/ methods
Follow-Up Studies
Genetic Testing
/ methods
Humans
Male
Maternal Age
Pregnancy
Pregnancy Outcome
Pregnancy Rate
Preimplantation Diagnosis
/ methods
Prognosis
Retrospective Studies
Sex Factors
Translocation, Genetic
aeuploidy rate
biopsy
blastocyst formation rate
clinical pregnancy rate
maternal age
paternal age
preimplantation genetic testing
reciprocal translocation
Journal
Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782
Informations de publication
Date de publication:
2021
2021
Historique:
received:
02
05
2021
accepted:
08
07
2021
entrez:
9
8
2021
pubmed:
10
8
2021
medline:
11
2
2022
Statut:
epublish
Résumé
To determine the effect of gender of reciprocal chromosomal translocation on blastocyst formation and pregnancy outcome in preimplantation genetic testing, including different parental ages. This was a retrospective cohort study that enrolled 1034 couples undergoing preimplantation genetic testing-structural rearrangement on account of a carrier of reciprocal chromosomal translocation from the Reproductive Medicine Center of the First Affiliated Hospital of Zhengzhou University from January 2015 to December 2019. Group A represented 528 couples in which the man was the carrier of reciprocal translocation and group B represented 506 couples in which the woman was the carrier of reciprocal translocation. All patients were divided into two groups according to their age: female age<35 and female age≥35. Furthermore, the differences in blastocyst condition and pregnancy outcome between male and female carriers in each group were further explored according to their father's age. The blastocyst formation rate of group A (55.3%) is higher than that of group B (50%) and the results were statistically significant (P<0.05). The blastocyst formation rate of group A is higher than that of group B, no matter in young maternal age or in advanced maternal age (P<0.05). The blastocyst formation rate in maternal age<35y and paternal age<30y in group A(57.1%) is higher than that of Group B(50%); Similarly, the blastocyst formation rate in maternal age≥35 and paternal age≥38y(66.7%) is higher than that of Group B(33.3%)(all P<0.05). There was no difference in fertilization rate, aeuploidy rate, clinical pregnancy rate, miscarriage rate and live birth rate between Group A and Group B. When the carrier of reciprocal translocation is male, the blastocyst formation rate is higher than that of female carrier. While there is no significant difference between the two in terms of fertilization rate, aeuploidy rate, clinical pregnancy rate, miscarriage rate and live birth rate.
Identifiants
pubmed: 34367071
doi: 10.3389/fendo.2021.704299
pmc: PMC8334865
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
704299Commentaires et corrections
Type : ErratumIn
Informations de copyright
Copyright © 2021 Song, Shi, Yang, Bu, Jin, Huo and Zhang.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
BMC Pregnancy Childbirth. 2020 Jul 3;20(1):388
pubmed: 32620095
Fertil Steril. 2017 Jan;107(1):19-26
pubmed: 27793378
Fertil Steril. 2014 Mar;101(3):656-663.e1
pubmed: 24355045
Front Endocrinol (Lausanne). 2020 Jul 21;11:424
pubmed: 32793112
Prenat Diagn. 1998 Dec;18(13):1437-49
pubmed: 9949444
Am J Med Genet A. 2010 Jun;152A(6):1428-33
pubmed: 20503317
Hum Reprod Update. 2019 Jan 1;25(1):15-33
pubmed: 30395265
Fertil Steril. 2011 Jul;96(1):134-42
pubmed: 21596375
Am J Obstet Gynecol. 2004 Jun;190(6):1707-11; discussion 1711-3
pubmed: 15284776
Hum Reprod. 2012 Sep;27(9):2843-9
pubmed: 22736325
Front Endocrinol (Lausanne). 2019 Mar 19;10:154
pubmed: 30941103
Fertil Steril. 2014 Nov;102(5):1318-23
pubmed: 25154676
Fertil Steril. 2018 Jul 1;110(1):113-121
pubmed: 29908770
Hum Reprod. 2019 Feb 1;34(2):380-387
pubmed: 30576528
Expert Rev Mol Diagn. 2017 Dec;17(12):1071-1088
pubmed: 29039978
Proc Natl Acad Sci U S A. 2016 Oct 18;113(42):11907-11912
pubmed: 27688762
J Assist Reprod Genet. 2018 Mar;35(3):403-408
pubmed: 29063503
Hum Reprod. 2010 Jul;25(7):1843-8
pubmed: 20511301
Int J Clin Exp Med. 2015 Mar 15;8(3):4575-80
pubmed: 26064387
Genet Med. 2020 Dec;22(12):1944-1955
pubmed: 32807973
Hum Reprod. 2018 Apr 1;33(4):757-767
pubmed: 29579270
Syst Biol Reprod Med. 2013 Feb;59(1):34-7
pubmed: 23050806
PLoS One. 2015 Sep 09;10(9):e0135734
pubmed: 26352861
Front Endocrinol (Lausanne). 2021 Feb 23;12:652990
pubmed: 33708177
Curr Opin Pediatr. 2009 Dec;21(6):703-8
pubmed: 19881348
Hum Reprod. 2011 Jun;26(6):1270-83
pubmed: 21502182
Fertil Steril. 2012 Sep;98(3):675-80
pubmed: 22683012
Fertil Steril. 2011 Jul;96(1):e58-65
pubmed: 21575938
Endocr Rev. 2009 Aug;30(5):465-93
pubmed: 19589949
Reprod Biomed Online. 2012 Jan;24(1):83-90
pubmed: 22116068
Front Endocrinol (Lausanne). 2019 Feb 20;10:94
pubmed: 30842755
Basic Clin Androl. 2017 Jan 21;27:2
pubmed: 28127436
J Assist Reprod Genet. 2017 Jan;34(1):51-59
pubmed: 27822654
Clin Genet. 2009 Oct;76(4):315-25
pubmed: 19793305